Centessa Pharmaceuticals Plc (CNTA)
39.76
+0.06
(+0.15%)
USD |
NASDAQ |
May 20, 16:00
39.76
0.00 (0.00%)
After-Hours: 18:24
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 6.152B |
| 52 Week High (Daily) | |
| 52 Week Low (Daily) | |
| All-Time High (Daily) | |
| Year to Date Total Returns (Daily) | |
| 1 Month Total Returns (Daily) | |
| 1 Year Total Returns (Daily) | 223.8% |
| Valuation | |
| PE Ratio | -- |
| PE Ratio (Forward) | |
| PS Ratio | -- |
| Price to Book Value | 12.62 |
| EV to EBITDA | |
| Dividend | |
|---|---|
| Dividend | -- |
| Dividend Yield (Forward) | |
| Financials | |
| Revenue (5 Year Growth) | |
| Revenue (Quarterly YoY Growth) | |
| EPS Diluted (5 Year Growth) | |
| EPS Diluted (Quarterly YoY Growth) | |
| Debt to Equity Ratio | 0.2433 |
| Return on Equity | |
| Return on Assets | |
| Risk | |
| Beta (5Y) | |
| Max Drawdown (5Y) | -- |
Profile
| Centessa Pharmaceuticals Plc operates as clinical-stage pharmaceutical company, which engages in discovering and developing medicines that delivers transformational to patients. Its portfolio include preclinical to phase three uncorrelated programs spanning diseases with high unmet need across oncology, hematology, immunology, inflammation, neuroscience, and rare diseases. The company was founded on October 26, 2020 and is headquartered in Altrincham, the United Kingdom. |
| URL | http://centessa.com |
| Investor Relations URL | https://investors.centessa.com/ |
| HQ State/Province | Cambridgeshire |
| Sector | Health Care |
| Industry | Biotechnology |
| Next Earnings Release | Aug. 11, 2026 (est.) |
| Last Earnings Release | May. 14, 2026 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |
Profile
| Centessa Pharmaceuticals Plc operates as clinical-stage pharmaceutical company, which engages in discovering and developing medicines that delivers transformational to patients. Its portfolio include preclinical to phase three uncorrelated programs spanning diseases with high unmet need across oncology, hematology, immunology, inflammation, neuroscience, and rare diseases. The company was founded on October 26, 2020 and is headquartered in Altrincham, the United Kingdom. |
| URL | http://centessa.com |
| Investor Relations URL | https://investors.centessa.com/ |
| HQ State/Province | Cambridgeshire |
| Sector | Health Care |
| Industry | Biotechnology |
| Next Earnings Release | Aug. 11, 2026 (est.) |
| Last Earnings Release | May. 14, 2026 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |